Montpellier, France, May 11, 2016 – MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing innovative surgical assistance robots, today announced that 100 spinal surgeries have successfully been performed with ROSA® Spine, its robotic-assistive device for minimally-invasive surgery of the spine.
Surgeries utilizingROSA® Spine have been performed by:
- Dr. Michel Lefranc, a neurosurgeon at Amiens-Picardy University Hospital (France),
- Prof. Michael Winking at Klinikum Osnarbrück (Germany),
- Dr. Juan Torres-Reveron at Miami Valley Hospital in Dayton, Ohio (United States),
- Dr. Carlos Botella at Hospital La Fe à Valencia (Spain).
The 100th case was performed by Dr. Michel Lefranc. “Having performed several procedures with ROSA® Spine, I have been extremely pleased with its accuracy and versatility,” said Dr. Lefranc. “The assistance of the robot allows the surgeon to perform the surgery as it was previously planned.”
ROSA® Spine received the CE Mark in 2014 and was granted FDA clearance in the U.S. in January 2016.
“The 100th ROSA® Spine procedure is a significant milestone for our Company that only scratches the surface of the potential opportunities for our ROSA robotic surgery system,” said Bertin Nahum, CEO and founder of Medtech. “This achievement continues to further validate our technology as an innovative approach in the spine market.”